About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
Key points
- Opioid toxidrome: respiratory depression + CNS depression +/- miosis.
- Ventilation is the priority; give bag-mask ventilation and oxygen before/with naloxone if apneic.
- Naloxone reverses respiratory depression but may precipitate withdrawal; titrate to adequate breathing, not full alertness.
- Long-acting opioids, methadone, sustained-release preparations, and fentanyl analogs may require repeat naloxone or infusion.
- After reversal, offer harm reduction, take-home naloxone, and buprenorphine initiation/referral when appropriate.
Overview
Opioid toxicity causing respiratory depression, CNS depression, and miosis, treated with airway support and titrated naloxone. Emergency management focuses on early recognition, stabilization, targeted investigation, and prompt definitive therapy while avoiding common pitfalls tested on USMLE Step 2 CK.
Epidemiology
This presentation is encountered in emergency and acute care settings. Risk varies by exposure, comorbidity, age, mechanism, and timeliness of treatment. Morbidity and mortality increase when recognition is delayed or when airway, breathing, circulation, antidotal therapy, or definitive source control is postponed.
Clinical Features
Symptoms
Found unresponsive, difficult to arouse, or with slowed breathing after possible opioid exposure
Snoring, gurgling, apnea, cyanosis, or aspiration event
History of heroin, fentanyl, prescription opioid, methadone, oxycodone, hydrocodone, morphine, or buprenorphine exposure
Co-ingestion with benzodiazepines, alcohol, gabapentinoids, or sedatives may blunt naloxone response
Withdrawal after naloxone: agitation, vomiting, diarrhea, yawning, piloerection, pain, tachycardia
Signs
Respiratory rate <12/min, shallow breathing, apnea, hypoxemia, or hypercapnia
CNS depression: somnolence, stupor, coma
Miosis is classic but may be absent with hypoxia, co-ingestion, or certain opioids
Needle marks, transdermal patches, pill bottles, powder, or paraphernalia
Pulmonary edema, aspiration, rhabdomyolysis, or compartment syndrome after prolonged down time
Investigations
First-line
Clinical diagnosisDo not wait for toxicology testing when opioid overdose is suspected; treat respiratory depression immediately.
Pulse oximetry and capnographyOxygen saturation may lag; end-tidal CO2 helps assess ventilation.
Point-of-care glucoseCheck all altered mental status patients because hypoglycemia can mimic overdose.
Second-line
ECGEvaluate co-ingestions; methadone can prolong QT and cause torsades.
Basic labsBMP, blood gas if significant hypoventilation, CK/renal function if prolonged immobilization, acetaminophen level if combination products possible.
Chest X-rayIf hypoxemia, aspiration, pulmonary edema, trauma, or persistent respiratory symptoms.
Specialist
Toxicology / addiction medicineFor recurrent toxicity, buprenorphine initiation, complex co-ingestion, body stuffing/packing, or pediatric exposure.
Management
AHA resuscitation guidance, CDC overdose prevention guidance, and ACEP emergency care practice1
Immediate resuscitation
- Assess airway, breathing, circulation; call for help and place on monitor.
- Open airway, suction, oxygen, and bag-mask ventilation for apnea or inadequate respirations.
- Naloxone if opioid-induced respiratory depression suspected.
- If no pulse, start CPR and follow ACLS; naloxone does not replace resuscitation.
2
Naloxone dosing
- Start low in opioid-dependent patients when not apneic: 0.04-0.1 mg IV and titrate every 2-3 minutes to adequate breathing.
- Larger initial doses such as 0.4-2 mg IV/IN/IM are appropriate for apnea, severe hypoventilation, or prehospital use.
- Repeat doses may be needed for fentanyl analogs or long-acting opioids.
- Naloxone infusion can be used for recurrent respiratory depression.
3
Observation and complications
- Observe until mental status and respirations remain stable after naloxone wears off.
- Long-acting opioid exposures require longer observation or admission.
- Treat aspiration, pulmonary edema, rhabdomyolysis, hypothermia, and trauma as indicated.
4
Harm reduction and treatment linkage
- Provide take-home naloxone and overdose prevention counseling.
- Assess readiness for medication treatment; initiate buprenorphine when moderate withdrawal is present and no contraindication.
- Offer referral to addiction treatment and social support.
Complications
- Hypoxic brain injury: From prolonged apnea or hypoventilation
- Aspiration pneumonitis/pneumonia: Depressed airway reflexes and vomiting after naloxone
- Noncardiogenic pulmonary edema: Can occur after opioid overdose or reversal
- Rhabdomyolysis/compartment syndrome: Prolonged immobilization while unconscious
- Recurrent respiratory depression: Naloxone duration may be shorter than the opioid
USMLE Step 2 CK Exam Tips
- 1Opioid overdose triad = coma, respiratory depression, miosis.
- 2The life-saving intervention is ventilation; naloxone is not a substitute for bag-mask ventilation.
- 3Titrate naloxone to breathing, not to complete arousal.
- 4Methadone overdose can recur and prolong QT — observe/admit and check ECG.
- 5Acetaminophen level is important when opioid-acetaminophen combination products are possible.
- 6Pinpoint pupils are helpful but not required.
Put your reading into practice
Topic-specific question practice is not linked for this article yet.
Choose USMLE Step 2 CK questions from the existing bank. General exam practice covers your selected topics; it is not filtered to this article. Your usual question-bank access applies.
Choose USMLE Step 2 CK practiceAfter your session, return to this section to revisit the reading and choose your next review.
Verified Sources & References
related resources
Save your place and choose what comes next
Emergency Medicine · Article 12 of 18